IGES creates new company in France: IGES France Pharma Consulting

17.10.2023 14:35

The IGES Group continues to grow and has founded a new subsidiary in France. IGES France Pharma Consulting provides strategic and health economics consulting services to drug developers and manufacturers seeking to bring products to market in France and Europe.

The company is embedded in the IGES Group's existing, comprehensive Europe-wide service network for the life sciences industry. The group has subsidiaries in six European countries and advises on the market launch and pricing of medical innovations. IGES UK Pharma Consulting was founded in 2022, offering parallel services for the United Kingdom.

“France is the second largest pharmaceutical market in Europe after Germany and an important entry country for pharmaceutical companies for their innovations. “With IGES France Pharma Consulting, we can now also cover the French market as part of European launch projects,” says the head of the IGES Group, Professor Bertram Häussler.

Häussler also acts as managing director of IGES France Pharma Consulting. The company's operational director is Pierre Moïse, who is moving into this role from the consulting company IQVIA. Moïse is an economist who has worked as a life sciences consultant for international companies and organizations for more than 15 years. His focus is on questions of market access and developments in international health and research policy.